Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Medicale (MCLE) Operating Income (2020 - 2025)

Medicale's Operating Income history spans 6 years, with the latest figure at -$8654.0 for Q3 2025.

  • For Q3 2025, Operating Income rose 44.2% year-over-year to -$8654.0; the TTM value through Sep 2025 reached -$33493.0, up 38.78%, while the annual FY2025 figure was -$33493.0, 38.78% up from the prior year.
  • Operating Income reached -$8654.0 in Q3 2025 per MCLE's latest filing, down from -$3575.0 in the prior quarter.
  • In the past five years, Operating Income ranged from a high of -$3575.0 in Q2 2025 to a low of -$19307.0 in Q4 2023.
  • Average Operating Income over 5 years is -$10023.7, with a median of -$8654.0 recorded in 2025.
  • Peak YoY movement for Operating Income: crashed 121.56% in 2023, then surged 61.51% in 2025.
  • A 5-year view of Operating Income shows it stood at -$18096.0 in 2021, then skyrocketed by 51.85% to -$8714.0 in 2022, then crashed by 121.56% to -$19307.0 in 2023, then rose by 22.33% to -$14995.0 in 2024, then soared by 42.29% to -$8654.0 in 2025.
  • Per Business Quant, the three most recent readings for MCLE's Operating Income are -$8654.0 (Q3 2025), -$3575.0 (Q2 2025), and -$6269.0 (Q1 2025).